Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.17%
#6 Bedrock Bedrock +70.28%
#7 Prom Prom +40.32%
#8 Cysic Cysic +39.09%
#9 COTI COTI +38.17%
#10 Playnance Playnance +34.56%
Coin of the day
Wrapped One Wrapped One
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
GlobeImmune, Inc. GlobeImmune, Inc.

GlobeImmune, Inc.

GBIM
Classificação em ações #42634
GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and... GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therapeutic products for both cancer and infectious diseases. Central to its development efforts is its unique Tarmogen platform. The company's pipeline includes several key candidates: For infectious diseases: GS-4774 is currently in Phase 2 clinical trials, designed to treat individuals chronically infected with the hepatitis B virus who are also on oral antiviral suppressive therapy. Additionally, GlobeImmune has various other infectious disease programs in the preclinical stage, such as GI-19000 for tuberculosis, GI-2010 for human immunodeficiency virus (HIV), and GI-18000 for hepatitis D virus infections. For oncology: GlobeImmune is advancing GI-6301, which targets cancers characterized by the expression of the brachyury protein. GI-6207 is progressing through Phase 2 clinical trials for medullary thyroid cancer. Furthermore, GI-4000 is a significant asset, undergoing Phase 2b clinical trials for resected pancreatic cancer, and is also in separate Phase 2 trials for non-small cell lung cancer and colorectal cancer. To support its endeavors, GlobeImmune maintains strategic alliances with industry leaders such as Gilead Sciences, Inc. and Celgene Corporation.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$575.00
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar GlobeImmune, Inc. (GBIM)

Categoria

Healthcare
Preço GBIM com a capitalização de mercado de B
GlobeImmune, Inc. GlobeImmune, Inc.
GBIM
$0.0001
Capitalização de mercado de GlobeImmune, Inc.(GBIM)
Valor de mercado: $575.00
Em August 2026, GlobeImmune, Inc. tem uma capitalização de mercado de $575.00. Isso faz com que GlobeImmune, Inc. seja a 42634th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de GlobeImmune, Inc. de 2014 a 2026
GBIM comparado com o topo de 5 mais populares stocks
Preço para GBIM Ativo B Capitalização de mercado de B Resultados
GlobeImmune, Inc. GlobeImmune, Inc.
$943,650 $575.00
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.426T +943,650,177,897.04%
GlobeImmune, Inc. GlobeImmune, Inc.
$771,635 $575.00
Apple Inc. Apple Inc.
AAPL
$4.437T +771,635,369,298.26%
GlobeImmune, Inc. GlobeImmune, Inc.
$721,305 $575.00
Alphabet Inc. Alphabet Inc.
GOOG
$4.148T +721,305,276,853.57%
GlobeImmune, Inc. GlobeImmune, Inc.
$637,190 $575.00
Microsoft Corporation Microsoft Corporation
MSFT
$3.664T +637,189,673,900.00%
GlobeImmune, Inc. GlobeImmune, Inc.
$502,478 $575.00
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.889T +502,478,171,900.00%